IDSA: Experimental Rx may be option in drug-resistant HIV
(HealthDay)—The intravenous drug ibalizumab might revolutionize the treatment of HIV patients who don't respond to existing drugs, according to research presented at the annual meeting of the Infectious Diseases Society ...
Oct 29, 2016
0
0